Please login to the form below
Kaken
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Kaken's Japan sales performance.
The flexible salesforce
By contrast, rates in Japan have not gone above 3% in 2020, in Germany they peaked at 8% and are now down to 3% and in the UK the peak of
Gavi says 76 wealthy countries have committed to COVAX vaccine facility
According to Berkley, over 70 nations have now signed up to the facility, including Japan, Norway and Germany, to procure vaccines through the COVAX facility for their respective nations.
Takeda to sell Japan consumer health unit for $2.3bn
Deal helps to reduce debt accrued from Shire takeover. Takeda is on the verge of selling its consumer health unit in Japan for up to $2.3bn to Blackstone Group, an
Gut instincts lead Takeda to GI pipeline success
Our motivation is clear. IBD has also been on the rise even in places where historically it didn’t have much of an impact, such as China, Japan, South-East Asia
AZ strengthens Daiichi Sankyo partnership with new ADC deal
Both companies will jointly develop and commercialise DS-1062 worldwide, apart from in Japan where Daiichi will retain exclusive rights.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
- New study identifies drugs that are safe to use in COVID-19 treatment
- Novacyt launches diagnostic test to differentiate between COVID-19 and flu
- Surviving cancer: a new era for patients
- UK COVID-19 vaccine ‘challenge trials’ could intentionally infect participants with virus
- Pfizer’s ALK inhibitor Lorbrena hits the mark in head-to-head lung cancer trial
- BMS eyes approval for second Opdivo combo in kidney cancer
- Live Webinar: Leveraging Digital Technologies to Create Valuable KOL Engagements & Empower Patients
- Live Webinar: Harnessing Technology to Improve Health and Healthcare
- Novavax starts first phase 3 COVID-19 vaccine trial in the UK
- Lilly’s Verzenio scores a win in early-stage breast cancer
- FDA sets January decision date for Xalkori in ALK-positive lymphoma
- Q&A: Isabel Gibson
PMHub
Iguazu
Iguazu Ltd is a digital healthcare agency, delivering tactical and innovative solutions. WHAT WE DO We are Closed Loop Marketing...
Latest intelligence
- Surviving cancer: a new era for patients
- Now more than ever, a shift in perspective is needed...
- Crisis? No problem!
- Issues planning & management for pharma spokespeople, by Andrew Smith...
- Are patient recruitment and retention rates rising or falling?
- First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Quick links
Infographics
